Filing Details
- Accession Number:
- 0001209191-15-085342
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-15 16:55:14
- Reporting Period:
- 2015-12-11
- Filing Date:
- 2015-12-15
- Accepted Time:
- 2015-12-15 16:55:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1461993 | Cempra Inc. | CEMP | Pharmaceutical Preparations (2834) | 262644445 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1630330 | W. David Oldach | 6320 Quadrangle Drive Suite 360 Chapel Hill NC 27517 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-12-11 | 8,222 | $2.28 | 9,322 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-12-11 | 8,222 | $30.33 | 1,100 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2015-12-15 | 1,778 | $2.28 | 2,878 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-12-15 | 1,778 | $30.00 | 1,100 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2015-12-11 | 8,222 | $0.00 | 8,222 | $2.28 |
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2015-12-15 | 1,778 | $0.00 | 1,778 | $2.28 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
18,125 | 2021-02-28 | No | 4 | M | Direct | |
16,347 | 2021-02-28 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | $23.51 | 2024-12-31 | 23,000 | 23,000 | Direct | |
Common Stock | Employee Stock Option (Right to Buy) | $13.10 | 2024-01-07 | 7,500 | 7,500 | Direct | |
Common Stock | Employee Stock Option (Right to Buy) | $6.64 | 2023-03-06 | 10,000 | 10,000 | Direct | |
Common Stock | Employee Stock Option (Right to Buy) | $6.63 | 2023-01-17 | 14,087 | 14,087 | Direct | |
Common Stock | Employee Stock Option (Right to Buy) | $7.47 | 2022-03-20 | 20,000 | 20,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2024-12-31 | 23,000 | 23,000 | Direct |
2024-01-07 | 7,500 | 7,500 | Direct |
2023-03-06 | 10,000 | 10,000 | Direct |
2023-01-17 | 14,087 | 14,087 | Direct |
2022-03-20 | 20,000 | 20,000 | Direct |
Footnotes
- This exercise and sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The option vests according to the following schedule: 1/48th of the shares vest at the end of each month over 48 months, beginning after 01/01/2015.
- The option vests according to the following schedule: 1/48th of the shares vest at the end of each month over 48 months, beginning after 01/01/2014.
- The option vested according to the following schedule: 1/4th of the shares vest at the end of each quarter, beginning after 01/01/2013.
- The option vested according to the following schedule: 1/4th of the shares vest at the end of each quarter, beginning after 01/01/2013.
- The option vested on the one-year anniversary of the 03/21/2012 grant date.
- The option vests according to the following schedule: 1/4th of the shares vest on the one-year anniversary of the 03/01/2011 grant date; 1/36th of the remaining shares vest at the end of each month over the next 36 months.